Latest on Pharmaceutical Industry


Merck to Acquire Immune Design

Merck , known as MSD outside the United States and Canada, and Immune Design, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Immune Desig..Read More...

QIAGEN is partnering with Ares Genetics to drive global combat against antibiotic-resistant pathogens

QIAGEN NV today announced a far-reaching agreement with Ares Genetics, a subsidiary of Curetis NV, known for the development of innovative bioinformatics and test solutions. The solutions are designed to enable faster pr..Read More...



Saudi INPHEX 2019

Riyadh International Convention & Exhibition Center,
Saudi Arabia,
Global Exhibition Services


Pharmaceutical Sciences 2019

Conference Series LLC LTD

Press Releases

Cell & Gene Immunotherapy Biotech, Vycellix, to Establish Headquarters in Tampa

Vycellix Inc today announced that the Company founded by leading medical researchers at Swedens world renowned Karolinska Institutet will establish its US headquarters in Tampa Florida The Vycellix team initially compris.. Read More...

Nexus Pharmaceuticals Receives FDA Approval for Prochlorperazine Edisylate Injection, USP

Nexus Pharmaceuticals announced today it has received US Food and Drug Administration FDA approval for Prochlorperazine Edisylate Injection USP in 10mg2mL vial The launch further expands our generic injectable portfol.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer